Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

73.48 -1.25 (-1.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
2 Top Biotech Stocks Defying the Bear Market
The best may be yet to come for these companies. 
Via The Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
You can get in early on these potential winners. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
Both stocks have outperformed the broader market in the last 12 months. 
Via The Motley Fool
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Today's market loser could be tomorrow's market winner. 
Via The Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
There's no guarantee that any stock will deliver 2 times returns. But the chances for these stocks look pretty good. 
Via The Motley Fool
Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance. 
Via Investor's Business Daily
Analyst Ratings for Axsome Therapeutics
Via Benzinga
Expert Ratings for Axsome Therapeutics
Via Benzinga
Why Shares of Axsome Therapeutics Fell Wednesday
The biopharmaceutical company announced a $225 million stock sale. 
Via The Motley Fool
3 Explosive Stocks to Buy Right Now
These stocks are poised to pop in the not-too-distant future. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Piper Sandler raised the price target for Chegg, Inc. (NYSE: CHGG) from $11 to $13. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Chegg shares rose 19.9% to $12.03 in pre-market... 
Via Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
These companies are coming into their own. 
Via The Motley Fool
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q2 sales of $46.7 million, beating the consensus of $40.19 million.  
Via Benzinga
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
AXSM earnings call for the period ending June 30, 2023. 
Via The Motley Fool
3 Fantastic Growth Stocks to Buy in August
These stocks could be poised to soar. 
Via The Motley Fool
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
There's lots of upside potential for these drugmakers. 
Via The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector. 
Via InvestorPlace
Baidu To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Monday
Keybanc boosted the price target for Camping World Holdings, Inc. (NYSE: CWH) from $28 to $36. Keybanc analyst Noah Zatzkin maintained an Overweight rating. Camping World shares rose 1.4% to $32.04 in... 
Via Benzinga
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good. 
Via The Motley Fool
5 Top Stocks for July
This basket of stocks has it all, including growth, dividend income, and value. 
Via The Motley Fool
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
Why Is Xponential Fitness (XPOF) Stock Up 19% Today?
Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research. 
Via InvestorPlace
Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today?
Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering. 
Via InvestorPlace
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock
Markets could have a tough time building on gains from Tuesday. 
Via The Motley Fool
Axsome Therapeutics Stock Is Moving Lower: What's Going On?
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock. 
Via Benzinga
The Best Stocks to Invest $20,000 in Right Now
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
2 Low-Priced Stocks That Could Make You Richer
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
They're not monsters now -- but just give them some time. 
Via The Motley Fool
3 Biotech Stocks to Buy as Companies Ink Major Deals
Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.